Musso Maria, Giannella Maddalena, Antonini Mario, Bordi Eugenio, Ettorre Giuseppe Maria, Tessitore Loretta, Mariano Andrea, Capone Alessandro
Second Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani , Rome.
Infectious Diseases Unit, Sant'Orsola Malpighi Hospital , Bologna.
Infect Dis Rep. 2014 Jun 24;6(2):5374. doi: 10.4081/idr.2014.5374. eCollection 2014 May 13.
Candida norvegensis is an emerging fluconazole-resistant pathogen isolated in most cases from skin and mucous membranes of immunocompromized patients. Documented invasive candidiasis (IC) due to C. norvegensis has been rarely reported, thus the clinical features of patients at risk for this pathogen are poorly defined. We report a liver transplant patient who developed IC due to C. norvegensis and review other cases of C. norvegensis IC published in the literature.
挪威念珠菌是一种新出现的对氟康唑耐药的病原体,大多数情况下是从免疫功能低下患者的皮肤和黏膜中分离出来的。由挪威念珠菌引起的侵袭性念珠菌病(IC)的病例报告很少,因此这种病原体感染风险患者的临床特征尚不明确。我们报告了一名因挪威念珠菌感染而发生IC的肝移植患者,并回顾了文献中发表的其他挪威念珠菌IC病例。